Wearable Sensor-Based Assessments for Remotely Screening Early-Stage Parkinson’s Disease

Author:

Johnson Shane1,Kantartjis Michalis1,Severson Joan1,Dorsey Ray23,Adams Jamie L.23,Kangarloo Tairmae4ORCID,Kostrzebski Melissa A.23,Best Allen1,Merickel Michael1ORCID,Amato Dan1,Severson Brian1,Jezewski Sean1,Polyak Steve1,Keil Anna1,Cosman Josh5,Anderson David1ORCID

Affiliation:

1. Clinical Ink, Winston-Salem, NC 27101, USA

2. Center for Health and Technology, University of Rochester Medical Center, Rochester, NY 14623, USA

3. Department of Neurology, University of Rochester Medical Center, Rochester, NY 14623, USA

4. Takeda Pharmaceuticals, Cambridge, MA 02142, USA

5. AbbVie Pharmaceuticals, North Chicago, IL 60064, USA

Abstract

Prevalence estimates of Parkinson’s disease (PD)—the fastest-growing neurodegenerative disease—are generally underestimated due to issues surrounding diagnostic accuracy, symptomatic undiagnosed cases, suboptimal prodromal monitoring, and limited screening access. Remotely monitored wearable devices and sensors provide precise, objective, and frequent measures of motor and non-motor symptoms. Here, we used consumer-grade wearable device and sensor data from the WATCH-PD study to develop a PD screening tool aimed at eliminating the gap between patient symptoms and diagnosis. Early-stage PD patients (n = 82) and age-matched comparison participants (n = 50) completed a multidomain assessment battery during a one-year longitudinal multicenter study. Using disease- and behavior-relevant feature engineering and multivariate machine learning modeling of early-stage PD status, we developed a highly accurate (92.3%), sensitive (90.0%), and specific (100%) random forest classification model (AUC = 0.92) that performed well across environmental and platform contexts. These findings provide robust support for further exploration of consumer-grade wearable devices and sensors for global population-wide PD screening and surveillance.

Funder

Biogen

Takeda

Critical Path for Parkinson’s Consortium 3DT Initiative

Publisher

MDPI AG

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3